Bimodal cardiac dysfunction in an animal model of iron overload

Journal of Laboratory and Clinical Medicine

Volumn 140, Issue 4, 2002, Pages 263-271

  Yang, Tianen ^a,b,c   Dong, Wei Qiang ^a,b,c   Kuryshev, Yuri A ^a,b,c   Obejero Paz, Carlos ^a,b,c   Levy, Matthew N ^a,b,c   Brittenham, Gary M ^a,b,c   Kiatchoosakun, Songsak ^a,b,c   Kirkpatrick, Darryl ^a,b,c   Hoit, Brian D ^a,b,c   Brown, Arthur M ^a,b,c  

^a Rammelkamp Center for Education and Research   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036794258     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2002.127725     Document Type: Article

References (31)

1. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalessemia. Blood 1997;89:739-61.
2. Brittenham GM. Disorders of iron metabolism: iron deficiency and overload. In: Hoffman R, Benz EJ, Shattil SJ, et al, eds. Hematology: basic principles and practice. New York: Churchill Livingstone, 1998:492-523.
3. Hershko C, Link G. Cabantchik I. Pathophysiology of iron overload. Ann N Y Acad Sci 1998;850:191-201.
4. Carthew P, Dorman BM, Edwards RE, Francis JR, Smith AG. A unique rodent model for both the cardiotoxic and hepatotoxic effects of prolonged iron-overload. Lab Invest 1993;69:217-22.
5. Lesnefsky EJ. Tissue iron overload and mechanisms of iron-catalyzed oxidative injury. Adv Exp Med Biol 1994;366:129-46.
6. Engle MA, Erlanson M, Smith CH. Late cardiac complications of chronic, severe, refractory anemia with hemochromatosis. Circulation 1964;30:698-705.
7. Rahko PS, Salerni R, Uretsky BF. Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overload. J Am Coll Cardiol 1986;8:436-40.
8. Wacker P, Halperin DS, Balmer-Ruedin D, Oberhansli I, Wyss M. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. Chest 1993;103:1276-8.
9. Politi A, Sticca M, Galli M. Reversal of haemochromatotic cardiomyopathy in beta thalassaemia by chelation therapy. Br Heart J 1995;73:486-7.
10. Davis BA, Porter JB. Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia. Blood 2000;95:1229-36.
11. Kuryshev YA, Brittenham GM, Fujioka H, Kannan P, Shieh CC, Cohen SA, et al. Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes: implications for the arrythmogenesis of human siderotic heart disease. Circulation 1999;100:675-83.
12. Carthew P, Smith AG, Hider RC, Dorman B, Edwards RE, Francis JR. Potentiation of iron accumulation in cardiac myocytes during the treatment of iron overload in gerbils with the hydroxypyridinone iron chelator CP94. Biometals 1994;7:267-71.
13. Grupp G. Derived indices of myocardial function in isolated working-performing hearts. In: Methods in pharmacology. New York: Plenum, 1984:129-139.
14. Ng WA, Grupp IL, Subramaniam A, Robbins J. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res 1991;68:1742-50.
15. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
16. Hoit BD. Echocardiographic assessment of the mouse heart and aorta. In: Hoit BD, Walsh RA, eds. Cardiovascular physiology in the genetically engineered mouse, 2nd ed. Boston: Kluwer, 2002.
17. Desai KH, Sato R, Schauble E, Barsh GS, Kobilka BK, Bernstein D. Cardiovascular indexes in the mouse at rest and with exercise: new tools to study models of cardiac disease. Am J Physiol 1997;272:H1053-61.
18. Overmoyer BA, McLaren CE, Brittenham GM. Uniformity of liver density and nonheme (storage) iron distribution. Arch Pathol Lab Med 1987;111:549-54.
19. Buja LM, Roberts WC. Iron in the heart: etiology and clinical significance. Am J Med 1971;51:209-21.
20. Hershko C, Link G, Konijn AM, Juerta M, Rosenmann E, Reinus C. The iron-loaded gerbil model revisited: effects of deferoxamine and deferiprione treatment. J Lab Clin Med 2002;139:50-8.
21. Suarez WA, Snyder SA, Berman BB, Brittenham GM, Patel CR. Preclinical cardiac dysfunction in transfusion-dependent children and young adults detected with low-dose dobutamine stress echocardiography. J Am Soc Echocardiogr 1998;11:948-56.
22. Hahalis, G, Manolis AS, Gerasimidou I, Alexopoulos D, Sitafidis G, Kourakli A, et al. Right ventricular diastolic function in beta-thalassemia major: echocardiographic and clinical correlates. Am Heart J 2001;141:428-34.
23. Fiorillo A, Farina V, D'Amore R, Scippa L, Cortese P, DeChiara C. Longitudinal assessment of cardiac status by echocardiographic evaluation of left ventricular diastolic function in thalassaemic children. Acta Paediatr 2000;89:436-41.
24. Jessup M, Manno CS. Diagnosis and management of iron-induced heart disease in Cooley's anemia. Ann N Y Acad Sci 1998;850:242-50.
25. Hoit BD, Khan ZU, Pawloski-Dahm CM, Walsh RA. In vivo determination of left ventricular wall stress-shortening relationship in normal mice. Am J Physiol 1997;272:H1047-52.
26. Hoit BD, Shao Y, Gabel M, Walsh RA. Disparate effects of early pressure overload hypertrophy on velocity-dependent and force-dependent indices of ventricular performance in the conscious baboon. Circulation 1995;91:1213-20.
27. Schmidt AG, Kadambi VJ, Ball N, Sato Y, Walsh RA, Kranias EG, et al. Cardiac-specific overexpression of calsequestrin results in left ventricular hypertrophy, depressed force-frequency relation and pulsus alternans in vivo. J Mol Cell Cardiol 2000;32:1735-44.
28. Hoit DB. Restrictive, obliterative and infiltrative cardiomyopathies. In: Fuster V, Alexander RW, O'Rourke RA, eds. Hurst's The Heart, ed 10. New York: McGraw-Hill, 2001:1989-2000.
29. Liu P, Olivieri N. Iron-overload cardiomyopathies: new insights into an old disease. Cardiovasc Drugs Ther 1994;8:101-10.
30. Silvestre JS, Mallat Z, Tamarat R, Duriez M, Tedgui A, Levy BI. Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis. Circ Res 2001;89:259-64.
31. Bartfay WJ, Dawood F, Wen WH, Lehotay DC, Hou D, Bartfay E, et al. Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron overload. Cardiovasc Res 1999;43:892-900.